Wednesday, January 30, 2019
Botulinum Toxin Products
Brian M. Buroker
Gibson, Dunn & Crutcher LLP
Medytox Inc., Allergan PLC and Allergan, Inc.
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Botulinum Toxin Products, Processes for Manufacturing or Relating to Same and Certain Products Containing Same. The proposed respondents are Daewoong Pharmaceuticals Co., Ltd., South Korea; Daewood Co., Ltd., South Korea and Evolus, Inc., Irvine, CA.